BRCA1 and breast carcinoma: In a German study that aimed to evaluate the efficacy of US for the early detection of breast cancer in BRCA1/2 carriers screened by semi-annual US in combination with annual MMG and MRI, 3 of 27 (11.1%) detected tumors were found in the semi-annual US.